Peptilogics
Bradd Picone is currently the VP, CMC and Technical Operations at Peptilogics, having previously held roles at Arthrex, Carmell Therapeutics, and Cohera Medical, Inc. Bradd's expertise lies in manufacturing, technology transfer, and process engineering within the biotechnology industry. With a background in Chemical Engineering and Mathematics, Bradd brings valuable skills to their current role at Peptilogics.
Peptilogics
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.